More OncoSil Medical Ltd news
OncoSil Medical LtdASX: OSL

Security Class Reinstatement to Quotation - OSLOE

Mar 17, 2026 at 10:10 PM EDT · Issued by OncoSil Medical Ltd

Filed with ASX · Mar 17, 2026 at 10:10 PM EDT · 1 page · English

On 6ix: 6ix.com/news/security-class-reinstatement-to-quotation-osloe

OncoSil Medical Ltd on 6ix

Story so far

  • Security Class Suspension from QuotationMar 11, 2026

Earlier from OncoSil Medical

  • Security Class Suspension from QuotationMar 10
  • Appendix 4D and Half Year AccountsFeb 23
  • CEO Remuneration UpdateFeb 11
  • Capital Raising PresentationFeb 3
  • ProspectusFeb 3

Later from OncoSil Medical

  • OncoSil Medical Receives TGA Approval in AustraliaMay 19
  • OncoSil progresses HDE with US FDAJun 8
  • OncoSil Selected for Major European Pancreatic Cancer StudyJul 1
  • OncoSil Medical Files for FDA ApprovalJul 2
  • OncoSil Medical Completes Manufacturing ValidationJul 12
All OncoSil Medical news releases↗

Follow OncoSil Medical into a list and get an email when it puts out news.

Follow OncoSil Medical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer